Come and join us across the globe
 Founded by Pr. Jacques Moret 
Sign In

NEWS

PRESS RELEASE

Sensome announces initiation of clinical trial assessing its tissue micr...

PARIS, FRANCE - FEBRUARY 12TH, 2024 – Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today enrollment of the first patients into a feasibility clinical study using the Clotild® Smart Guidewire in peripheral artery disease (PAD). Clotild® was designated a breakthrough medical device for use in brain arteries by the FDA in 2021.

BREAKING NEWS

BREAKING NEWS

BREAKING NEWS

Come and join us across the globe
 Founded by Pr. Jacques Moret